Prostatic Neoplasms: all 6,484 studies

Page 23 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• Efavirenz in Treating Patients With Metastatic Prostate CancerCompletedNCT00964002Phase 2Results posted
• Validation of a Screening Tool in Geriatric OncologyCompletedNCT00963911Not applicableResults posted
• A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate CancerCompletedNCT00958477Phase 1Results posted
• Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate CancerTerminatedNCT00953576Phase 1/2Results posted
• Vitamin D Supplementation in Veterans With Early-Stage Prostate CancerCompletedNCT00953225Phase 2Results posted
• Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyCompletedNCT00950911Phase 3Results posted
• A Trial of Degarelix in Patients With Prostate CancerCompletedNCT00946920Phase 3Results posted
• Safety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerCompletedNCT00946881Phase 1/2Results posted
• Effects of Sulforaphane on Normal Prostate TissueCompletedNCT00946309Phase 1/2Results posted
• Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen BlockadeTerminatedNCT00945477Phase 2Results posted
• A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate CancerCompletedNCT00942578Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerCompletedNCT00942331Phase 3Results posted
• Stereotactic Body Radiotherapy (SBRT) for Prostate CancerCompletedNCT00941915Not applicableResults posted
• Lenalidomide and GM-CSF in Treating Patients With Prostate CancerCompletedNCT00939510Phase 1/2Results posted
• Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical SlingCompletedNCT00937833Not applicableResults posted
• Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyTerminatedNCT00937768Phase 2Results posted
• Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesCompletedNCT00936975Phase 2Results posted
• Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerCompletedNCT00936390Phase 3Results posted
• Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation TherapyCompletedNCT00931528Phase 3Results posted
• A Study of Degarelix in Patients With Prostate CancerCompletedNCT00928434Phase 3Results posted
• Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate CancerCompletedNCT00928252Phase 1/2Results posted
• Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate CancerCompletedNCT00928174Phase 1/2Results posted
• Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossCompletedNCT00925600Phase 3Results posted
• Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate CancerTerminatedNCT00924807Phase 1/2Results posted
• A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate CancerCompletedNCT00924469Phase 2Results posted
• Positron Emission Tomography and Magnetic Resonance Imaging for Prostate CancerCompletedNCT00924313Phase 1/2Results posted
• A Study of Patients Receiving High-Dose Rate BrachytherapyCompletedNCT00924027Phase 2Results posted
• Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer PatientsCompletedNCT00919035Phase 2Results posted
• Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone MetastasisTerminatedNCT00918645Not applicableResults posted
• Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate CancerTerminatedNCT00918385Phase 2Results posted
• Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer SubjectsCompletedNCT00918229Not applicableResults posted
• FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate CancerTerminatedNCT00917865Phase 2Results posted
• An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the ProstateCompletedNCT00913263Phase 1/2Results posted
• Postoperative Pain Control for ProstatectomyCompletedNCT00913068Not applicableResults posted
• GM-CSF in Treating Patients With Relapsed Prostate CancerCompletedNCT00908141Phase 2Results posted
• RNActive®-Derived Therapeutic VaccineTerminatedNCT00906243Phase 1/2Results posted
• Open Label Study of Sipuleucel-T in Metastatic Prostate CancerCompletedNCT00901342Phase 2Results posted
• Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior ChemotherapyCompletedNCT00895310Phase 2Results posted
• Performance Evaluation of the AMS CONTINUUM™ DeviceCompletedNCT00894933Not applicableResults posted
• Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical ProstatectomyCompletedNCT00888654Phase 2Results posted
• Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate CancerTerminatedNCT00887640Phase 2Results posted
• A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal TherapyCompletedNCT00887458Phase 2Results posted
• Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT00887198Phase 3Results posted
• Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer PatientsCompletedNCT00884273Phase 3Results posted
• Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer PatientsTerminatedNCT00879619Phase 1/2Results posted
• Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After CastrationCompletedNCT00878436Phase 1/2Results posted
• Study of Immunotherapy to Treat Advanced Prostate CancerCompletedNCT00861614Phase 3Results posted
• Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate CancerTerminatedNCT00861471Phase 1/2Results posted
• Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate CancerTerminatedNCT00860158Phase 2Results posted
• 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate CancerActive, not recruitingNCT00859781Phase 2Results posted
• Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate CancerCompletedNCT00859027Phase 4Results posted
• Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate CarcinomaTerminatedNCT00851682Not applicableResults posted
• Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate CancerCompletedNCT00849121Phase 2Results posted
• Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate CancerCompletedNCT00838201Phase 3Results posted
• Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate CancerCompletedNCT00833248Phase 3Results posted
• TKI258 in Castrate Resistant Prostate CancerCompletedNCT00831792Phase 2Results posted
• Study of Hypofractionated Proton Beam Radiation Therapy for Prostate CancerCompletedNCT00831623Not applicableResults posted
• Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate CancerTerminatedNCT00831233Phase 3Results posted
• Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate CancerCompletedNCT00828308Phase 2Results posted
• Telephone Counseling: Men With Prostate Cancer & PartnersCompletedNCT00822510Phase 1Results posted
• The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate CancerCompletedNCT00819247Phase 2Results posted
• Dose Finding Trial With a New Treatment (Degarelix) for Prostate CancerCompletedNCT00819156Phase 2Results posted
• Investigation of a New Trial Drug (FE200486) in Prostate Cancer PatientsCompletedNCT00818623Phase 2Results posted
• Vaccine Therapy in Treating Patients With Non-Metastatic Prostate CancerTerminatedNCT00814892Phase 2Results posted
• Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT00814788Phase 2Results posted
• Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the ProstateCompletedNCT00809991Phase 2Results posted
• Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate CancerTerminatedNCT00809458Phase 3Results posted
• Intermittent Treatment With Degarelix of Patients Suffering From Prostate CancerCompletedNCT00801242Phase 3Results posted
• Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate CancerTerminatedNCT00786682Phase 2Results posted
• A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate CancerTerminatedNCT00780975Phase 2Results posted
• PROvenge Treatment and Early Cancer TreatmentCompletedNCT00779402Phase 3Results posted
• Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local TherapyCompletedNCT00776594Phase 2Results posted
• Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerTerminatedNCT00773773Not applicableResults posted
• Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate CancerTerminatedNCT00769652Not applicableResults posted
• Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate CancerTerminatedNCT00753220Phase 1/2Results posted
• Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate CancerCompletedNCT00751790Phase 3Results posted
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate CancerCompletedNCT00744497Phase 3Results posted
• Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and OlderCompletedNCT00741039Phase 2Results posted
• Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate CancerCompletedNCT00738673Phase 2Results posted
• Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical ProstatectomyCompletedNCT00737893Phase 2Results posted
• Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00736645Phase 2Results posted
• Multimodality Phase II Study in Prostate CancerTerminatedNCT00734851Phase 2Results posted
• Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerCompletedNCT00726596Phase 2Results posted
• Sipuleucel-T as Neoadjuvant Treatment in Prostate CancerCompletedNCT00715104Phase 2Results posted
• To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) AntigenCompletedNCT00715078Phase 2Results posted
• Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate CancerCompletedNCT00714753Phase 2Results posted
• MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate CancerCompletedNCT00706966Not applicableResults posted
• A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate CancerCompletedNCT00706628Phase 2Results posted
• CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate CancerTerminatedNCT00702923Phase 1Results posted
• PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive TreatmentCompletedNCT00694551Not applicableResults posted
• Proton Therapy for Low and Intermediate Risk Prostate CancerCompletedNCT00693238Not applicableResults posted
• Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal TherapyTerminatedNCT00686036Phase 2Results posted
• Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing SurgeryCompletedNCT00685516Not applicableResults posted
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate CancerCompletedNCT00683475Phase 2Results posted
• Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate CancerTerminatedNCT00678015Phase 2Results posted
• Green Tea Extract and Prostate CancerCompletedNCT00676780Phase 2Results posted
• Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyTerminatedNCT00676650Phase 3Results posted
• Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate CancerCompletedNCT00673127Phase 2Results posted
• Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to ProstatectomyCompletedNCT00672594Phase 2Results posted
• Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate CancerTerminatedNCT00670046Phase 2Results posted

← Prostatic Neoplasms overview